Phosphoproteomic profiling reveals a defined genetic program for osteoblastic lineage commitment of human bone marrow–derived stromal stem cells

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 6.
Figure 6.

PRKD1 regulates HDAC7 localization in immortalized hMSCs. (A) Western blot images of HDAC and PRKD1 phosphorylation levels during osteoblast differentiation, n = 2. (B) Western blot of HDAC and PRKD1 phosphorylation 30 min and 1 h after induction of osteoblastic differentiation, with and without PRKD1 inhibitor (PKDi), n = 2. (C) Detection of HDAC7 in unstimulated hMSCs (Control), 30 min after osteoblastic induction (30 min OD) with and without PKDi or PMA-treated hMSCs, n = 3. (D) mRNA levels of CTGF, CEBPD, CYR61, and ALPL in relative expression 24 h after osteoblastic differentiation with and without PKDi. (E) Quantitation of alkaline phosphatase (ALPL) activity on day 6 of osteoblast differentiation of hMSC transfected with control nontargeting siRNA (siCtrl) or two independent siRNAs targeting PRKD1 (siPRKD1 #1, siPRKD1 #2). For D and E: (*) P < 0.05, Student's t-test; n = 3.

This Article

  1. Genome Res. 30: 127-137

Preprint Server